Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiichiro Terayama

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
International Journal of Rehabilitation Research. Internationale Zeitschrift Fur Rehabilitationsforschung. Revue Internationale De Recherches De Readaptation|May 6, 2025
Ankle plantar-dorsal flexion exercises mitigate orthostatic hypotension in patients with neurodegenerative diseasesTakashi Akiba, Keiichiro Terayama, Akihiro Ogawa, et al.
Progress in Rehabilitation Medicine|May 19, 2025
Preoperative Physical Factors Predictive of Clinical Outcomes after Total Knee ArthroplastyArata Nakajima, Keiichiro Terayama, Takashi Akiba, et al.
Modern Rheumatology|October 17, 2015
Radiographic progression of large joint damage in patients with rheumatoid arthritis treated with biological disease-modifying anti-rheumatic drugsArata Nakajima, Yasuchika Aoki, Masato Sonobe, et al.
Modern Rheumatology|March 9, 2017
Health assessment questionnaire-disability index (HAQ-DI) score at the start of biological disease-modifying antirheumatic drug (bDMARD) therapy is associated with radiographic progression of large joint damage in patients with rheumatoid arthritisArata Nakajima, Yasuchika Aoki, Keiichiro Terayama, et al.
Case Reports in Neurology|June 30, 2020
Probable Creutzfeldt-Jakob Disease Presenting Dementia and Urinary RetentionYosuke Aiba, Ryuji Sakakibara, Ayako Iimura, et al.
International Heart Journal|November 30, 2022
Cardio-Ankle Vascular Index Reflects the Efficacy of Waon Therapy in Heart Failure PatientsTakahiro Nakagami, Kazuhiro Shimizu, Keiichi Hirano, et al.
Cureus|December 23, 2021
Serum Reactive Oxygen Metabolites as a Predictor of Clinical Disease Activity Index, Simplified Disease Activity Index, and Boolean Remissions in Rheumatoid Arthritis Patients Treated With Biologic AgentsArata Nakajima, Keiichiro Terayama, Masato Sonobe, et al.
Modern Rheumatology|October 5, 2018
Predictive factors for radiographic progression of large joint damage in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs (bDMARDs): Results of 3 to 4 years of follow-upArata Nakajima, Keiichiro Terayama, Masato Sonobe, et al.
BMC Rheumatology|January 1, 2020
Serum levels of reactive oxygen metabolites at 12 weeks during tocilizumab therapy are predictive of 52 weeks-disease activity score-remission in patients with rheumatoid arthritisArata Nakajima, Keiichiro Terayama, Masato Sonobe, et al.
Case Reports in Neurology|January 29, 2019
Young-Onset Dementia with Lewy BodiesYosuke Aiba, Ryuji Sakakibara, Tsuyoshi Ogata, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Rehabilitation Research. Internationale Zeitschrift Fur Rehabilitationsforschung. Revue Internationale De Recherches De Readaptation|May 6, 2025
Ankle plantar-dorsal flexion exercises mitigate orthostatic hypotension in patients with neurodegenerative diseasesTakashi Akiba, Keiichiro Terayama, Akihiro Ogawa, et al.
Progress in Rehabilitation Medicine|May 19, 2025
Preoperative Physical Factors Predictive of Clinical Outcomes after Total Knee ArthroplastyArata Nakajima, Keiichiro Terayama, Takashi Akiba, et al.
Modern Rheumatology|October 17, 2015
Radiographic progression of large joint damage in patients with rheumatoid arthritis treated with biological disease-modifying anti-rheumatic drugsArata Nakajima, Yasuchika Aoki, Masato Sonobe, et al.
Modern Rheumatology|March 9, 2017
Health assessment questionnaire-disability index (HAQ-DI) score at the start of biological disease-modifying antirheumatic drug (bDMARD) therapy is associated with radiographic progression of large joint damage in patients with rheumatoid arthritisArata Nakajima, Yasuchika Aoki, Keiichiro Terayama, et al.
Case Reports in Neurology|June 30, 2020
Probable Creutzfeldt-Jakob Disease Presenting Dementia and Urinary RetentionYosuke Aiba, Ryuji Sakakibara, Ayako Iimura, et al.
International Heart Journal|November 30, 2022
Cardio-Ankle Vascular Index Reflects the Efficacy of Waon Therapy in Heart Failure PatientsTakahiro Nakagami, Kazuhiro Shimizu, Keiichi Hirano, et al.
Cureus|December 23, 2021
Serum Reactive Oxygen Metabolites as a Predictor of Clinical Disease Activity Index, Simplified Disease Activity Index, and Boolean Remissions in Rheumatoid Arthritis Patients Treated With Biologic AgentsArata Nakajima, Keiichiro Terayama, Masato Sonobe, et al.
Modern Rheumatology|October 5, 2018
Predictive factors for radiographic progression of large joint damage in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs (bDMARDs): Results of 3 to 4 years of follow-upArata Nakajima, Keiichiro Terayama, Masato Sonobe, et al.
BMC Rheumatology|January 1, 2020
Serum levels of reactive oxygen metabolites at 12 weeks during tocilizumab therapy are predictive of 52 weeks-disease activity score-remission in patients with rheumatoid arthritisArata Nakajima, Keiichiro Terayama, Masato Sonobe, et al.
Case Reports in Neurology|January 29, 2019
Young-Onset Dementia with Lewy BodiesYosuke Aiba, Ryuji Sakakibara, Tsuyoshi Ogata, et al.
Pageof 2